Wellness Advisors are available
Mon-Fri 9am-5pm MST
North America:
Call or Text: 1-855-955-1114
International:
Call: 1-587-271-1110
Web Chat
Schedule Consult
A new randomized, double-blind, placebo-controlled trial published in a leading psychiatry journal is adding to a growing body of evidence that something foundational—yet often overlooked—is playing a central role in adolescent mental health:
Micronutrient status.
This wasn’t a small observational study or a loose association. This was a controlled clinical trial examining whether a broad-spectrum micronutrient formula could meaningfully impact one of the most difficult—and increasingly common—clinical presentations in teens:
Severe irritability.
Irritability in adolescents isn’t just “moodiness.”
It’s one of the most impairing symptoms across multiple psychiatric conditions—cutting across depression, anxiety, ADHD, and behavioral disorders. It’s also one of the strongest predictors of:
Aggression
Emotional dysregulation
Family dysfunction
Long-term psychiatric risk
And yet, treatment options are limited.
Medications can help—but they often come with trade-offs. Therapy is effective—but not always accessible or sufficient on its own.
So when a randomized controlled trial shows meaningful improvements in core symptoms, behavior, and even suicidal ideation, it deserves attention.
This study—part of the BEAM (Balancing Emotions in Adolescents with Micronutrients) trial—looked at:
132 adolescents (ages 12–17)
Moderate to severe irritability
No concurrent psychiatric medications
Randomized to:
Broad-spectrum micronutrients
Placebo
Duration:
8 weeks
Fully blinded
Clinician-monitored
This is exactly the kind of design needed to separate real effects from placebo.
Teens taking micronutrients showed:
Greater improvements in irritability
Better emotional reactivity control
Improved overall functioning
compared to placebo.
This alone is notable.
But it gets more compelling.
In teens diagnosed with Disruptive Mood Dysregulation Disorder (DMDD)—a condition defined by chronic, severe irritability:
64% responded to micronutrients
12.5% responded to placebo
That’s not a marginal difference.
That’s a 5x greater likelihood of improvement. (PubMed)
With:
Relative Risk (RR): 4.05
Number Needed to Treat (NNT): 1.9
In clinical terms, that’s an unusually large effect size—especially in psychiatry.
One of the most important findings:
Teens taking micronutrients showed greater reductions in suicidal thoughts compared to placebo. (PubMed)
This is critical.
Because suicidal ideation is often downstream of:
Chronic irritability
Cognitive overwhelm
Addressing upstream biology may be part of the solution.
Compared to placebo, micronutrient-treated teens experienced faster improvements in:
Clinician-rated irritability
Parent-rated mood (dysphoria)
Stress levels
Quality of life
Prosocial behavior (PubMed)
In some cases, families reported noticeable changes within weeks. (Health Research Council of New Zealand)
Beyond mood:
Improved conduct
Increased prosocial behavior
Better emotional control in real-life settings
These are the outcomes that actually change lives—not just scores on a scale.
One of the biggest concerns with any intervention—especially in teens—is safety.
In this study:
The treatment was well tolerated
The only significant side effect:
Mild, temporary diarrhea
(20.9% vs 6.2% placebo)
Importantly:
<10% reported difficulty with pill intake
No serious adverse effects.
This study doesn’t just show that micronutrients “help.”
It challenges a deeper assumption:
Whether psychiatric symptoms are purely psychological or require pharmacological suppression.
Instead, it supports a different model:
Micronutrients act as:
Cofactors for neurotransmitter synthesis
Regulators of mitochondrial energy production
Modulators of inflammation and oxidative stress
Without adequate nutrients, the brain literally cannot function optimally.
Even in developed countries:
Ultra-processed foods dominate
Nutrient density is lower
Demand on the brain is higher than ever
Researchers noted that even teens with “adequate diets” may still require additional nutritional support for optimal brain function. (Health Research Council of New Zealand)
What’s emerging across multiple studies is consistent:
Broad-spectrum micronutrients don’t target one symptom
They support systems-level brain function
Which is why we see improvements across:
Mood
Behavior
Stress
Social functioning
Not just one isolated metric.
This randomized controlled trial provides something rare in mental health research:
A biologically plausible intervention
With clinically meaningful outcomes
Backed by gold-standard methodology
Including:
Significant reductions in irritability
A 5x higher response rate in severe cases
Improvements in behavior and quality of life
And critically—reductions in suicidal ideation
All from addressing something foundational:
Nutritional sufficiency.
Rucklidge et al. Randomized controlled trial on micronutrients and adolescent irritability (BEAM study). (PubMed)
European Child & Adolescent Psychiatry (2025). Micronutrient treatment research. (Springer Link)
Health Research Council summary of BEAM trial findings. (Health Research Council of New Zealand)
Clinical summaries and reporting on trial outcomes. (Omnicuris)